LSD1 inhibition in pHGG: The key to unleashing immunotherapy?

Theodore P. Nicolaides; Rintaro Hashizume

doi:10.1093/neuonc/noaa171

LSD1 inhibition in pHGG: The key to unleashing immunotherapy?

Theodore P. Nicolaides^*, Rintaro Hashizume

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1237-1238
Number of pages	2
Journal	Neuro-oncology
Volume	22
Issue number	9
DOIs	https://doi.org/10.1093/neuonc/noaa171
State	Published - Sep 1 2020

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/neuonc/noaa171

Cite this

@article{3c7513565eb24a608dee3c4a770434ff,

title = "LSD1 inhibition in pHGG: The key to unleashing immunotherapy?",

author = "Nicolaides, {Theodore P.} and Rintaro Hashizume",

year = "2020",

month = sep,

day = "1",

doi = "10.1093/neuonc/noaa171",

language = "English (US)",

volume = "22",

pages = "1237--1238",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - LSD1 inhibition in pHGG

T2 - The key to unleashing immunotherapy?

AU - Nicolaides, Theodore P.

AU - Hashizume, Rintaro

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85092332105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092332105&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noaa171

DO - 10.1093/neuonc/noaa171

M3 - Editorial

C2 - 32678903

AN - SCOPUS:85092332105

SN - 1522-8517

VL - 22

SP - 1237

EP - 1238

JO - Neuro-oncology

JF - Neuro-oncology

IS - 9

ER -

LSD1 inhibition in pHGG: The key to unleashing immunotherapy?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this